M Toublanc

2.0k total citations
66 papers, 1.5k citations indexed

About

M Toublanc is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, M Toublanc has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 20 papers in Rheumatology and 14 papers in Surgery. Recurrent topics in M Toublanc's work include Prostate Cancer Diagnosis and Treatment (32 papers), Prostate Cancer Treatment and Research (30 papers) and Urologic and reproductive health conditions (19 papers). M Toublanc is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (32 papers), Prostate Cancer Treatment and Research (30 papers) and Urologic and reproductive health conditions (19 papers). M Toublanc collaborates with scholars based in France, United States and Algeria. M Toublanc's co-authors include V. Ravery, L Boccon-Gibod, V. Delmas, L. Boccon‐Gibod, M C Dauge-Geffroy, T Billebaud, A. Meulemans, L Boccon-Gibod, Liliane Boccon‐Gibod and L Boccon-Gibod and has published in prestigious journals such as Cancer, Ophthalmology and The Journal of Urology.

In The Last Decade

M Toublanc

63 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Toublanc France 20 1.1k 495 316 302 197 66 1.5k
Charles Jameson United Kingdom 23 809 0.7× 388 0.8× 351 1.1× 411 1.4× 81 0.4× 60 1.5k
J.W. Oosterhuis Netherlands 19 558 0.5× 205 0.4× 487 1.5× 788 2.6× 141 0.7× 36 1.5k
T. Kien Canada 22 691 0.6× 223 0.5× 315 1.0× 527 1.7× 44 0.2× 105 1.4k
Gencay Hatiboglu Germany 19 697 0.6× 163 0.3× 267 0.8× 221 0.7× 53 0.3× 65 1.1k
Muhammad T. Idrees United States 23 982 0.9× 398 0.8× 811 2.6× 1.2k 3.9× 160 0.8× 140 2.2k
Mehsati Herawi United States 23 993 0.9× 669 1.4× 275 0.9× 462 1.5× 43 0.2× 30 1.6k
John D. Coyne United Kingdom 21 314 0.3× 302 0.6× 243 0.8× 245 0.8× 105 0.5× 75 1.1k
C A van de Kaa Netherlands 15 590 0.5× 157 0.3× 165 0.5× 176 0.6× 94 0.5× 22 1.0k
Kristine M. Cornejo United States 20 620 0.6× 146 0.3× 405 1.3× 381 1.3× 108 0.5× 90 1.3k
Borislav A. Alexiev United States 19 342 0.3× 121 0.2× 322 1.0× 259 0.9× 180 0.9× 79 1.2k

Countries citing papers authored by M Toublanc

Since Specialization
Citations

This map shows the geographic impact of M Toublanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Toublanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Toublanc more than expected).

Fields of papers citing papers by M Toublanc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Toublanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Toublanc. The network helps show where M Toublanc may publish in the future.

Co-authorship network of co-authors of M Toublanc

This figure shows the co-authorship network connecting the top 25 collaborators of M Toublanc. A scholar is included among the top collaborators of M Toublanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Toublanc. M Toublanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravery, V., Vincent Hupertan, Sami Ben Rhouma, et al.. (2007). Prostate Cancer Characteristics in a Multiracial Community. European Urology. 53(3). 533–539. 20 indexed citations
2.
Majo, F., et al.. (2006). Pathologies épithéliales cornéennes et insuffisance en cellules souches limbiques. Journal Français d Ophtalmologie. 29(9). 1060–1069. 6 indexed citations
3.
Peyromaure, Michaël, Philippe Sèbe, Patrice Verpillat, et al.. (2002). Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guérin therapy. Urology. 59(3). 409–413. 38 indexed citations
4.
Dumonceau, O., et al.. (2002). [Innervation of Denonvilliers' recto-vesical septum. Anatomic study].. PubMed. 86(273). 17–20. 1 indexed citations
6.
Laissy, J.P., Marie‐Pierre Debray, M Toublanc, et al.. (2000). Renal carcinoma: diagnosis of venous invasion with Gd-enhanced MR venography. European Radiology. 10(7). 1138–1143. 36 indexed citations
7.
Vieillefond, Annick, B Cochand‐Priollet, M C Dauge-Geffroy, et al.. (1999). Recommandations pratiques pour les prélèvements prostatiques. Les Membres du Sous-Comité Prostate du Comité de Cancerologie de l'Association Française d'Urologie.. Annales de Pathologie. 19(6). 2 indexed citations
8.
Ravery, V., et al.. (1999). Diagnostic Value of Ten Systematic TRUS-Guided Prostate Biopsies. European Urology. 35(4). 298–303. 36 indexed citations
9.
Molinié, Vincent, Annick Vieillefond, B Cochand‐Priollet, et al.. (1999). [Recommendations for reforming prostatic specimens. Les Membres du Sous-Comité Prostate du Comité de Cancerologie de l'Association Française d'Urologie].. PubMed. 19(6). 549–56. 6 indexed citations
10.
Ravery, V., F Lamotte, C. Hennequin, et al.. (1998). Adjuvant radiation therapy for recurrent PSA after radical prostatectomy in T1–T2 prostate cancer. Prostate Cancer and Prostatic Diseases. 1(6). 321–325. 9 indexed citations
11.
12.
Ravery, V., et al.. (1996). Advances in the Assessmentof Clinically Localized ProstateCancer. European Urology. 29(3). 257–265. 7 indexed citations
13.
Cochereau, I., et al.. (1996). Ocular Involvement in Epstein-Barr Virus-associated T-cell Lymphoma. American Journal of Ophthalmology. 121(3). 322–324. 7 indexed citations
14.
Schmid, Hans‐Peter, V. Ravery, T Billebaud, et al.. (1996). Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels. Urology. 47(5). 699–703. 14 indexed citations
15.
Ravery, V., János Szabó, M Toublanc, et al.. (1996). A single positive prostate biopsy in six does not predict a low‐volume prostate tumour. British Journal of Urology. 77(5). 724–728. 32 indexed citations
16.
Hoang–Xuan, T., Bahram Bodaghi, M Toublanc, et al.. (1996). Scleritis and Mucosal-associated Lymphoid Tissue Lymphoma. Ophthalmology. 103(4). 631–635. 35 indexed citations
17.
Ravery, V., János Szabó, T Billebaud, et al.. (1996). [A single positive prostatic biopsy out of six systematic biopsies is not correlated with the intracapsular nature of the tumor on an individual level].. PubMed. 6(1). 70–5. 3 indexed citations
18.
Haab, F., L Boccon-Gibod, V. Delmas, L. Boccon‐Gibod, & M Toublanc. (1994). Perineal versus retropubic radical prostatectomy for T1, T2 prostate cancer. British Journal of Urology. 74(5). 626–629. 44 indexed citations
19.
Boucekkine, C., Jean‐Edmond Toublanc, N. Abbas, et al.. (1994). Clinical and anatomical spectrum in XX sex reversed patients. Relationship to the presence of Y specific DNA‐sequences. Clinical Endocrinology. 40(6). 733–742. 92 indexed citations
20.
Ravery, V., et al.. (1994). Predictive Value of Pathological Features for Progression after Radical Prostatectomy. European Urology. 26(3). 197–201. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026